Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics
Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics
Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics
The Unit is approved by major regulators like EMA, Europe; Health Canada, Anvisa, Brazil and TGA, Australia
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
The X CUBE 50 integrates ALPINION’s advanced X+ Architecture
The formulation is backed by over 80 clinical trials and 200 scientific publications
The move is expected to be crucial during health crises
The cleared system pairs a flexible nitinol implant with a deployable prong-locking mechanism, delivering rotational and length stability
India presents one of the world’s largest untapped opportunities for neurovascular screening
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Subscribe To Our Newsletter & Stay Updated